![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-demecolcine | increases expression | ISO | RGD:1312560 | 6480464 | Demecolcine results in increased expression of RGS20 mRNA | CTD | PMID:23649840 | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of RGS20 mRNA modified form, Estradiol results in increased expression of RGS20 protein modified form | CTD | PMID:22265196 | 17beta-estradiol 3-benzoate | decreases methylation | EXP | | 6480464 | estradiol 3-benzoate results in decreased methylation of RGS20 promoter | CTD | PMID:27415467 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1312560 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RGS20 mRNA | CTD | PMID:20106945, PMID:21632981 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RGS20 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RGS20 mRNA | CTD | PMID:32109520 | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | increases expression | ISO | RGD:1312560 | 6480464 | 2 more ... | CTD | PMID:26705709 | 2-hydroxypropanoic acid | decreases expression | ISO | RGD:1312560 | 6480464 | Lactic Acid results in decreased expression of RGS20 mRNA | CTD | PMID:30851411 | 3,3',5,5'-tetrabromobisphenol A | increases expression | ISO | RGD:1312561 | 6480464 | tetrabromobisphenol A results in increased expression of RGS20 mRNA | CTD | PMID:25172293 | 5-aza-2'-deoxycytidine | affects expression | ISO | RGD:1312560 | 6480464 | Decitabine affects the expression of RGS20 mRNA | CTD | PMID:23300844 | aflatoxin B1 | affects expression | ISO | RGD:1312560 | 6480464 | Aflatoxin B1 affects the expression of RGS20 protein | CTD | PMID:20106945 | aflatoxin B1 | increases expression | ISO | RGD:1312560 | 6480464 | Aflatoxin B1 results in increased expression of RGS20 mRNA | CTD | PMID:21632981 more ... | all-trans-retinoic acid | decreases expression | ISO | RGD:1312560 | 6480464 | Tretinoin results in decreased expression of RGS20 mRNA | CTD | PMID:23724009, PMID:33167477 | arsenite(3-) | increases methylation | ISO | RGD:1312560 | 6480464 | arsenite results in increased methylation of RGS20 promoter | CTD | PMID:23974009 | arsenite(3-) | multiple interactions | ISO | RGD:1312560 | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to RGS20 mRNA] | CTD | PMID:32406909 | benzo[a]pyrene | increases expression | ISO | RGD:1312560 | 6480464 | Benzo(a)pyrene results in increased expression of RGS20 mRNA | CTD | PMID:20106945 more ... | benzo[a]pyrene | affects methylation | ISO | RGD:1312560 | 6480464 | Benzo(a)pyrene affects the methylation of RGS20 intron | CTD | PMID:30157460 | beta-naphthoflavone | increases expression | ISO | RGD:1312560 | 6480464 | beta-Naphthoflavone results in increased expression of RGS20 mRNA | CTD | PMID:19737606 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of RGS20 mRNA | CTD | PMID:25181051 | bisphenol A | decreases methylation | ISO | RGD:1312560 | 6480464 | bisphenol A results in decreased methylation of RGS20 gene | CTD | PMID:31601247 | bisphenol A | decreases expression | ISO | RGD:1312561 | 6480464 | bisphenol A results in decreased expression of RGS20 mRNA | CTD | PMID:30951980 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of RGS20 gene | CTD | PMID:28505145 | bromobenzene | increases expression | EXP | | 6480464 | bromobenzene results in increased expression of RGS20 mRNA | CTD | PMID:32479839 | butan-1-ol | multiple interactions | ISO | RGD:1312560 | 6480464 | [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RGS20 mRNA | CTD | PMID:29432896 | cadmium atom | increases expression | ISO | RGD:1312560 | 6480464 | Cadmium results in increased expression of RGS20 mRNA | CTD | PMID:21172416 | cadmium atom | multiple interactions | ISO | RGD:1312560 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RGS20 mRNA | CTD | PMID:35301059 | cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of RGS20 promoter | CTD | PMID:22457795 | cadmium dichloride | multiple interactions | ISO | RGD:1312560 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RGS20 mRNA | CTD | PMID:35301059 | cisplatin | affects expression | ISO | RGD:1312560 | 6480464 | Cisplatin affects the expression of RGS20 mRNA | CTD | PMID:23300844 | cocaine | multiple interactions | ISO | RGD:1312561 | 6480464 | HDAC5 affects the reaction [Cocaine affects the expression of RGS20 mRNA] | CTD | PMID:17988634 | copper(II) sulfate | increases expression | ISO | RGD:1312560 | 6480464 | Copper Sulfate results in increased expression of RGS20 mRNA | CTD | PMID:19549813 | cyclosporin A | increases expression | ISO | RGD:1312560 | 6480464 | Cyclosporine results in increased expression of RGS20 mRNA | CTD | PMID:21632981, PMID:25562108 | cytarabine | increases expression | ISO | RGD:1312560 | 6480464 | Cytarabine results in increased expression of RGS20 mRNA | CTD | PMID:21198554 | diquat | increases expression | ISO | RGD:1312560 | 6480464 | Diquat results in increased expression of RGS20 mRNA | CTD | PMID:21172416 | disodium selenite | decreases expression | ISO | RGD:1312560 | 6480464 | Sodium Selenite results in decreased expression of RGS20 mRNA | CTD | PMID:18175754 | dorsomorphin | multiple interactions | ISO | RGD:1312560 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | entinostat | decreases expression | ISO | RGD:1312560 | 6480464 | entinostat results in decreased expression of RGS20 mRNA | CTD | PMID:26272509, PMID:27188386 | entinostat | multiple interactions | ISO | RGD:1312560 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RGS20 mRNA | CTD | PMID:27188386 | ethanol | multiple interactions | ISO | RGD:1312560 | 6480464 | [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RGS20 mRNA | CTD | PMID:29432896 | ethanol | affects splicing | ISO | RGD:1312561 | 6480464 | Ethanol affects the splicing of RGS20 mRNA | CTD | PMID:30319688 | formaldehyde | increases expression | ISO | RGD:1312560 | 6480464 | Formaldehyde results in increased expression of RGS20 mRNA | CTD | PMID:23649840 | fulvestrant | increases methylation | ISO | RGD:1312560 | 6480464 | Fulvestrant results in increased methylation of RGS20 gene | CTD | PMID:31601247 | gallic acid | increases expression | ISO | RGD:1312560 | 6480464 | Gallic Acid results in increased expression of RGS20 mRNA | CTD | PMID:34408198 | isobutanol | multiple interactions | ISO | RGD:1312560 | 6480464 | [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RGS20 mRNA | CTD | PMID:29432896 | lipopolysaccharide | increases expression | ISO | RGD:1312560 | 6480464 | Lipopolysaccharides results in increased expression of RGS20 mRNA | CTD | PMID:35811015 | lipopolysaccharide | multiple interactions | ISO | RGD:1312560 | 6480464 | [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RGS20 mRNA | CTD | PMID:35811015 | methyl methanesulfonate | increases expression | ISO | RGD:1312560 | 6480464 | Methyl Methanesulfonate results in increased expression of RGS20 mRNA | CTD | PMID:23649840 | methylphenidate | decreases expression | ISO | RGD:1312561 | 6480464 | Methylphenidate results in decreased expression of RGS20 mRNA | CTD | PMID:22470460 | N-nitrosodiethylamine | increases expression | ISO | RGD:1312561 | 6480464 | Diethylnitrosamine results in increased expression of RGS20 mRNA | CTD | PMID:24535843 | nickel atom | increases expression | ISO | RGD:1312560 | 6480464 | Nickel results in increased expression of RGS20 mRNA | CTD | PMID:25583101 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of RGS20 mRNA | CTD | PMID:33387578 | paraquat | increases expression | ISO | RGD:1312561 | 6480464 | Paraquat results in increased expression of RGS20 mRNA | CTD | PMID:28366735 | phenylmercury acetate | increases expression | ISO | RGD:1312560 | 6480464 | Phenylmercuric Acetate results in increased expression of RGS20 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | RGD:1312560 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RGS20 mRNA | CTD | PMID:27188386 | quercetin | increases expression | ISO | RGD:1312560 | 6480464 | Quercetin results in increased expression of RGS20 mRNA | CTD | PMID:21632981 | rac-lactic acid | decreases expression | ISO | RGD:1312560 | 6480464 | Lactic Acid results in decreased expression of RGS20 mRNA | CTD | PMID:30851411 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | RGD:1312560 | 6480464 | [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RGS20 mRNA | CTD | PMID:35811015 | SB 431542 | multiple interactions | ISO | RGD:1312560 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | increases expression | ISO | RGD:1312560 | 6480464 | Silicon Dioxide analog results in increased expression of RGS20 mRNA, Silicon Dioxide results in increased expression of RGS20 mRNA | CTD | PMID:25351596, PMID:25895662 | sodium arsenite | increases expression | ISO | RGD:1312560 | 6480464 | sodium arsenite results in increased expression of RGS20 mRNA | CTD | PMID:29301061 | temozolomide | decreases expression | ISO | RGD:1312560 | 6480464 | Temozolomide results in decreased expression of RGS20 mRNA | CTD | PMID:31758290 | topotecan | affects response to substance | ISO | RGD:1312560 | 6480464 | RGS20 protein affects the susceptibility to Topotecan | CTD | PMID:16217747 | trovafloxacin | increases expression | ISO | RGD:1312561 | 6480464 | trovafloxacin results in increased expression of RGS20 mRNA | CTD | PMID:35537566 | urethane | decreases expression | ISO | RGD:1312560 | 6480464 | Urethane results in decreased expression of RGS20 mRNA | CTD | PMID:28818685 | valproic acid | decreases methylation | ISO | RGD:1312560 | 6480464 | Valproic Acid results in decreased methylation of RGS20 gene | CTD | PMID:29154799 | valproic acid | decreases expression | ISO | RGD:1312560 | 6480464 | Valproic Acid results in decreased expression of RGS20 mRNA | CTD | PMID:28001369 | zinc atom | multiple interactions | ISO | RGD:1312560 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of RGS20 mRNA | CTD | PMID:18593933 | zinc(0) | multiple interactions | ISO | RGD:1312560 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of RGS20 mRNA | CTD | PMID:18593933 | |